Maud A W Hermans
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 27, 2025
Single-center off-label benralizumab use for refractory hypereosinophilic syndrome demonstrates satisfactory safety and efficacy.Yvonne Veltman, Anna M Aalbers, Maud A W Hermans
|May 21, 2022
Histopathological characteristics are instrumental to distinguish monomorphic from polymorphic maculopapular cutaneous mastocytosis in children.Maud A W Hermans, Suzanne G M A Pasmans, Nicolette J T Arends
|Jul 14, 2019
Systemic mastocytosis with normal serum tryptase: rule or exception?M A W Hermans, M W J Schreurs, P L A van Daele
|Jun 26, 2018
The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.Maud A W Hermans, Benjamin Schrijver, Conny C P A van Holten-Neelen
|Mar 24, 2018
Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double-blind, placebo-controlled challenge study.M A W Hermans, S Q A van der Vet, P M van Hagen
|May 11, 2017
Routine abdominal ultrasonography has limited value in the care for patients with indolent systemic mastocytosis.C L de Mol, M A W Hermans, R Gerth van Wijk
Pageof 1
